Wolverine Trading
BIS icon

Wolverine Trading’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Wolverine Trading’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,481
Closed -$267K – 4413
2017
Q2 		$283K Buy
+1,481
New +$323K ﹤0.01% 3131

Other funds holding BIS

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return

Wolverine Trading's BIS Position: Q3 2017 in Review

Wolverine Trading sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q3 2017, closing a stake of 1,481 shares — an estimated $267K sold.

Wolverine Trading first reported a position in BIS in Q2 2017 and held it in 1 quarter. The position peaked at $283K in Q2 2017. 9 funds tracked by Wall St. Rank hold BIS as of Q3 2017.

  • Wolverine Trading reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q3 2017 after selling out during the quarter.
  • Wolverine Trading sold 1,481 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2017, an estimated $267K.
  • Wolverine Trading first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2017 and held it in 1 quarter.
  • Wolverine Trading's ProShares UltraShort NASDAQ Biotechnology position peaked at $283K in Q2 2017.
  • 9 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2017.

Based on Wolverine Trading's 13F filing for Q3 2017, filed 15 Nov 2017.